Search
Search Results
##search.searchResults.foundPlural##
-
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4130PDF: 1577HTML: 9305Untitled: 306Untitled: 203Untitled: 190Untitled: 187Untitled: 205Untitled: 363 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3498PDF: 1333HTML: 2312Fi.1 Gritti.Rambaldi: 233 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5092PDF: 1996HTML: 11448Fig 1: 254Fig 2: 210Fig 3: 335Fig 4: 213Fig 5: 217Fig 6: 209Fig 7: 228Fig 8: 208 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
240PDF: 368Suppl. Files: 63HTML: 124 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1625PDF: 1873Suppl. Files: 182HTML: 107 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1359PDF: 1083HTML: 427 -
COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
1142PDF: 606HTML: 382 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
207PDF: 198HTML: 16 -
Is laboratory monitoring useful in DOACs management?
921PDF: 854HTML: 118 -
ADVANCES IN THE TREATMENT OF MALARIA
2919PDF: 1338HTML: 6145 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3357PDF: 1751HTML: 1166 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2338PDF: 851HTML: 450 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1452PDF: 901HTML: 10093cover letter to the editor: 188tile page: 271 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2305PDF: 755HTML: 2145Untitled: 250Untitled: 172Untitled: 204Untitled: 176Untitled: 194Untitled: 202Untitled: 207 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
873PDF: 752HTML: 231 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4428PDF: 1799HTML: 1471Figure 1: Age distribution of Pediatric cases: 242 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1771PDF: 766HTML: 239 -
-
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2233PDF: 1979HTML: 524 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
4043PDF: 1178HTML: 468 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1574PDF: 926HTML: 381







